Sign In
Buy TWST
$91.55
+0.220 (+0.241%)
At Close: Jul 31, 2026
NIO To Surge Around 105%? Plus Keybanc Predicts $165 For This Stock
02:05pm, Monday, 21'st Nov 2022 Benzinga
Keybanc raised the price target on AMETEK, Inc. (NYSE: AME) from $145 to $165. Keybanc analyst Steve Barger maintained an Overweight rating on the stock. AMETEK shares rose 0.9% to close at $139.32 o
4 Analysts Have This to Say About Twist Bioscience
01:00pm, Monday, 21'st Nov 2022 Benzinga
Analysts have provided the following ratings for Twist Bioscience (NASDAQ:TWST) within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
0
2
2
0
0
ConocoPhillips To Plunge Over 11%? Plus This Analyst Slashes PT On LiveOne By 25%
11:51am, Monday, 21'st Nov 2022 Benzinga
Societe Generale boosted the price target on ConocoPhillips (NYSE: COP) from $106 to $114. ConocoPhillips shares fell 2% to close at $128.59 on Friday.
HC Wainwright & Co. cut LiveOne, Inc. (NASD
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
01:45pm, Friday, 18'th Nov 2022 Zacks Investment Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of 28.91% and 0.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Twist Bioscience Corporation (TWST) Q4 2022 Earnings Call Transcript
10:18am, Friday, 18'th Nov 2022
Twist Bioscience Corporation (NASDAQ:TWST ) Q4 2022 Earnings Conference Call November 18, 2022 8:00 AM ET Company Participants Angela Bitting - Senior Vice President, Corporate Affairs & Chief ESG Off
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
09:55am, Friday, 18'th Nov 2022
Twist Bioscience (TWST) delivered earnings and revenue surprises of 28.91% and 0.56%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Twist Bioscience Stock Is Crashing This Week
12:48am, Friday, 18'th Nov 2022 The Motley Fool
Investors were spooked by a short-seller's allegations.
Why Twist Bioscience Stock Is Crashing This Week
07:48pm, Thursday, 17'th Nov 2022
Investors were spooked by a short-seller's allegations.
Twist Bioscience shares slide 20% after short seller compares synthetic DNA provider to Theranos, calling it a 'cash-burning inferno'
04:36pm, Wednesday, 16'th Nov 2022 MarketWatch
Twist Bioscience Corp. stock slid 20% Tuesday, after a damning short seller report compared the company to the failed blood-testing startup Theranos, calling it a "cash-burning inferno" and a "'synthe
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
10:01am, Wednesday, 16'th Nov 2022 Benzinga
Gainers
Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Tenax Therapeutics, Inc. (NASDAQ: TENX) jumped 45.7% to close at $0.1351 on Tuesday.
Exagen Inc.
Why Shares of Twist Bioscience Fell 19.92% on Tuesday
01:59am, Wednesday, 16'th Nov 2022 The Motley Fool
A negative report by a short-seller drove the biotech's shares downward.
Why Shares of Twist Bioscience Fell 19.92% on Tuesday
08:59pm, Tuesday, 15'th Nov 2022
A negative report by a short-seller drove the biotech's shares downward.
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session
06:15pm, Tuesday, 15'th Nov 2022 Benzinga
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Pineapple Energy Inc. (NASDAQ: PEGY) shares jumped 45% to $3.41 after the com
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
04:17pm, Tuesday, 15'th Nov 2022 Benzinga
U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
AMMO, Inc. (NASDAQ: POWW) shares tumbled 26% to $2
Why Is Twist Bioscience (TWST) Stock Down 18% Today?
11:45am, Tuesday, 15'th Nov 2022
Today, we're witnessing an example of how a short report can impact a stock. Reportedly, activist short seller Scorpion Capital just published a report about Twist Bioscience (NASDAQ: TWST ).
